K Number
K230134
Device Name
Laser Therapy Hair Growth Comb, Model: Lasercomb-001 & Lasercomb-002
Date Cleared
2023-05-23

(126 days)

Product Code
Regulation Number
890.5500
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Laser Therapy Hair Growth Comb is indicated to treat Androgenetic Alopecia, and promote hair growth in females who have Ludwig (Savin) I-4, II-1, II-2, or frontal patterns of hair loss and in males who have Norwood Hamilton Classifications of IIa to V and who both have Fitzpatrick Skin Types I to IV.
Device Description
Laser Therapy Hair Growth Comb is a hand-held comb-shaped low level laser therapy device that emits laser light designed to promote hair growth in women and men. The device provides distributed laser light to the scalp while the comb teeth simultaneously part the user's hair to ensure the laser light reaches the user's scalp. Lasercomb-001 contains 7 laser diodes, and Lasercomb-002 contains 9 laser diodes.
More Information

Not Found

No
The description focuses on the physical design and laser technology, with no mention of AI or ML.

Yes
The device is indicated to treat Androgenetic Alopecia and promote hair growth, which are therapeutic claims.

No

The device description and intended use clearly state that it is a therapy device (low level laser therapy) for promoting hair growth, not for diagnosing any condition.

No

The device description explicitly states it is a "hand-held comb-shaped low level laser therapy device that emits laser light," indicating it is a physical hardware device.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is to treat Androgenetic Alopecia and promote hair growth. This is a therapeutic purpose, not a diagnostic one.
  • Device Description: The device is a hand-held laser therapy device that emits light to the scalp. This is a physical intervention, not a test performed on biological samples.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting markers, or providing diagnostic information.

IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This device does not fit that description.

N/A

Intended Use / Indications for Use

Laser Therapy Hair Growth Comb is indicated to treat Androgenetic Alopecia, and promote hair growth in females who have Ludwig (Savin) I-4, II-1, II-2, or frontal patterns of hair loss and in males who have Norwood Hamilton Classifications of IIa to V and who both have Fitzpatrick Skin Types I to IV.

Product codes (comma separated list FDA assigned to the subject device)

OAP

Device Description

Laser Therapy Hair Growth Comb is a hand-held comb-shaped low level laser therapy device that emits laser light designed to promote hair growth in women and men. The device provides distributed laser light to the scalp while the comb teeth simultaneously part the user's hair to ensure the laser light reaches the user's scalp. Lasercomb-001 contains 7 laser diodes, and Lasercomb-002 contains 9 laser diodes.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

scalp

Indicated Patient Age Range

females who have Ludwig (Savin) I-4, II-1, II-2, or frontal patterns of hair loss and in males who have Norwood Hamilton Classifications of IIa to V and who both have Fitzpatrick Skin Types I to IV.

Intended User / Care Setting

Over-The-Counter Use (21 CFR 801 Subpart C)

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The following performance data were provided in support of the substantial equivalence determination.

  1. Biocompatibility Testing: The biocompatibility evaluation for the body-contacting components of Laser Therapy Hair Growth Comb was conducted in accordance with the "Use of International Standard ISO 10993-1, 'Biological Evaluation of Medical Devices -Part 1: Evaluation and Testing Within a Risk Management Process, Document Issued on June 16, 2016", as recognized by FDA. The testing was performed to, and passed, including:
  • ISO 10993-5:2009/(R)2014, Biological Evaluation of Medical Devices –Part 5: Tests for In Vitro Cytotoxicity
  • ISO 10993-10:2010. Biological Evaluation of Medical Devices -Part 10: Tests for Irritation and Skin Sensitization
  • ISO 10993-23 First edition 2021-01 Biological evaluation of medical devices Part 23: Tests for irritation
  1. Electrical and EMC Safety: Electrical safety and EMC safety testing was performed to, and passed, the following standards:
  • IEC 60601-1 Medical electrical equipment -Part 1: General requirements for basic safety and essential performance
  • IEC 60601-1-11 Medical electrical equipment -Part 1-11: General requirements for basic safety and essential performance -Collateral standard: Requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment
  • IEC 60601-1-2 Medical electrical equipment -Part 1-2: General requirements for basic safety and essential performance -Collateral standard: electromagnetic compatibility -Requirements and tests
    In addition, testing to IEC 60825-1 certifies the laser system to classification 3R, which is the same as the predicate devices. The battery conforms to IEC 62133.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K103368, K112524, K110233

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 890.5500 Infrared lamp.

(a)
Identification. An infrared lamp is a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating.(b)
Classification. Class II (special controls). The device, when it is an infrared therapeutic heating lamp, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9.

0

Image /page/0/Picture/0 description: The image contains two logos. On the left is the Department of Health and Human Services logo. On the right is the FDA logo, which includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.

June 12, 2023

Hubei YJT Technology Co.,Ltd % Gamma Zhang RA Manager Tacro Guangzhou Branch Rm. 501, No.55 West Tiyu Rd., Tianhe Dist., Guangzhou Guangdong Guangzhou, Guangdong 510000 China

Re: K230134

Trade/Device Name: Laser Therapy Hair Growth Comb, Model: Lasercomb-001 & Lasercomb-002 Regulation Number: 21 CFR 890.5500 Regulation Name: Infrared lamp Regulatory Class: Class II Product Code: OAP

Dear Gamma Zhang:

The Food and Drug Administration (FDA) is sending this letter to notify you of an administrative change related to your previous substantial equivalence (SE) determination letter dated May 23,2023. Specifically, FDA is updating this SE Letter as an administrative correction of incorrect trade name and model name in the 510(k) summary.

Please note that the 510(k) submission was not re-reviewed. For questions regarding this letter please contact Jianting Wang, OHT4: Office of Surgical and Infection Control Devices, Acting Assistant Director, jianting.wang@fda.hhs.gov

Sincerely,

Image /page/0/Picture/9 description: The image shows the name "Jianting Wang -S" in a large, sans-serif font. The text is black and appears to be the main subject of the image. The background is a light blue color, which provides contrast to the black text.

Jianting Wang Acting Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

1

Image /page/1/Picture/0 description: The image contains the logos of the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA). The HHS logo is on the left, featuring a stylized graphic of a human figure. To the right is the FDA logo, with the letters "FDA" in a blue square and the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.

May 23, 2023

Hubei YJT Technology Co.,Ltd % Gamma Zhang RA Manager Tacro Guangzhou Branch Rm. 501, No.55 West Tiyu Rd., Tianhe Dist., Guangzhou Guangdong Guangzhou, Guangdong 510000 China

Re: K230134

Trade/Device Name: Laser Therapy Hair Growth Comb, Model: Lasercomb-001 & Lasercomb-002 Regulation Number: 21 CFR 890.5500 Regulation Name: Infrared Lamp Regulatory Class: Class II Product Code: OAP Dated: April 7, 2023 Received: April 7, 2023

Dear Gamma Zhang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

2

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE(@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Jianting Wang -S

Jianting Wang Acting Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

3

Indications for Use

510(k) Number (if known) K230134

Device Name Laser Therapy Hair Growth Comb

Indications for Use (Describe)

Laser Therapy Hair Growth Comb is indicated to treat Androgenetic Alopecia, and promote hair growth in females who have Ludwig (Savin) I-4, II-1, II-2, or frontal patterns of hair loss and in males who have Norwood Hamilton Classifications of IIa to V and who both have Fitzpatrick Skin Types I to IV.

Type of Use (Select one or both, as applicable)

Research involving OFF-Label Substance Use
Investigational use of OFF-Label Substance

| | Prescription Use (Part 21 CFR 801 Subpart D)

|X | Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

4

510(k) Summary

K230134

"510(k) Summary" as required by 21 CFR Part 807.92.

Date: 2023-05-23

I. Submitter

Hubei YJT Technology Co.,Ltd. Room1-4 , 8F,Block7,Guannan Fuxing Pharmaceutical Park, No.62 Optical Valley Ave, East Lake High-tech Development Zone, Wuhan, Hubei Province, China Tel.: 027-87771565 Hua Xiang (RA engineer) Tel: +86 17364042492 Email: 528149645@qq.com

II. Correspondent Consultant

Tacro Guangzhou Branch Rm. 501, No.55 West Tiyu Rd., Tianhe Dist., Guangzhou, Guangdong Gamma Zhang(RA manager) Tel: +86 13433933949 Email: wbzhang@tacro.cn

III. Device

Type of 510(k): Traditional Common Name: Laser Therapy Hair Growth Comb Trade Name: Laser Therapy Hair Growth Comb Model: Lasercomb-001 & Lasercomb-002 Classification Name: Laser, Comb, Hair Regulation Number: 21 CFR 890.5500 Review Panel: General & Plastic Surgery Regulatory Class: II Product Code: OAP

IV. Predicate Device

ApplicantPredicate Device510(k) Number
Lexington International, LLCHairMax LaserComb Advanced 7, HairMax LaserComb Lux 9, Hairmax lasercomb professional 12K103368

5

510(k)s –Section 6. 510(k) Summary

| Lexington International,
LLC | HairMax LaserComb (Model:
HairMax Advanced 7) | K112524 |
|---------------------------------|--------------------------------------------------|---------|
| Lexington International,
LLC | HairMax LaserComb (Model:
HairMax Lux 9) | K110233 |

V. Device Description

Laser Therapy Hair Growth Comb is a hand-held comb-shaped low level laser therapy device that emits laser light designed to promote hair growth in women and men. The device provides distributed laser light to the scalp while the comb teeth simultaneously part the user's hair to ensure the laser light reaches the user's scalp. Lasercomb-001 contains 7 laser diodes, and Lasercomb-002 contains 9 laser diodes.

VI. Indications for Use

Laser Therapy Hair Growth Comb is indicated to treat Androgenetic Alopecia, and promote hair growth in females who have Ludwig (Savin) 1-4, II-2, or frontal patterns of hair loss and in males who have Norwood Hamilton Classifications of IIa to V and who both have Fitzpatrick Skin Types I to IV..

6

VII.Comparison of Technological Characteristics With the Predicate Device

Laser Therapy Hair Growth Comb raises no safety or efficacy concerns when compared to the predicate devices.

A technical comparison to the predicate is provided below:

| Comparison

ElementsSubject DevicePredicate Device IPredicate Device II
K NumberK230134K103368K112524
Trade nameLaser Therapy Hair
Growth CombHairMax LaserComb Advanced
7HairMax LaserComb Advanced
7
ModelLasercomb-001HairMax LaserComb Advanced
7HairMax LaserComb Advanced
7
Classification
nameInfrared LampInfrared LampInfrared Lamp
Product codeOAPOAPOAP
Intended
use/Indications
for UseLaser Therapy Hair
Growth Comb is indicated
to treat Androgenetic
Alopecia, and promote
hair growth in females
who have Ludwig (Savin)
I-4, II-1, II-2, or frontal
patterns of hair loss and in
males who have Norwood
Hamilton Classifications
of Ila to V and who both
have Fitzpatrick Skin
Types I to IV.The HairMax LaserComb
Advanced 7, Lux9, and the
Professional 12 models are
indicated to treat androgenetic
alopecia, promote hair growth
and help prevent further hair
loss in males who have
Norwood Hamilton
Classifications of Ila to V and
who both have Fitzpatrick Skin
Types I to IV.The HairMax LaserComb
Advanced 7 is indicated to treat
androgenetic alopecia
and promote hair growth in
females who have Ludwig
(Savin) Scale I-4, II-1, II-2, or
frontal and Fitzpatrick Skin
Types I to IV.
Location for useOTC applicationOTC applicationOTC application
Type of laserVisible red light-emitting
diodesVisible red light-emitting diodesVisible red light-emitting diodes
Wavelength650nm ± 10nm650nm ± 10nm650nm ± 10nm
Amount of laser
diodes777
Energy of per
laser diode4.63 mW, 4.56 mW, 4.66
mW, 4.78 mW, 4.86 mW,
4.78 mW, 4.89 mW ISO 10993-5:2009/(R)2014, Biological Evaluation of Medical Devices –Part 5: Tests for In Vitro Cytotoxicity
  • ISO 10993-10:2010. Biological Evaluation of Medical Devices -Part 10: Tests for Irritation and Skin Sensitization

  • ISO 10993-23 First edition 2021-01 Biological evaluation of medical devices Part 23: Tests for irritation

2)Electrical and EMC Safety

Electrical safety and EMC safety testing was performed to, and passed, the following standards:

  • IEC 60601-1 Medical electrical equipment -Part 1: General requirements for basic safety and essential performance

  • IEC 60601-1-11 Medical electrical equipment -Part 1-11: General requirements for basic safety and essential performance -Collateral standard: Requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment

  • IEC 60601-1-2 Medical electrical equipment -Part 1-2: General requirements for basic safety and essential performance -Collateral standard: electromagnetic compatibility -Requirements and tests

In addition, testing to IEC 60825-1 certifies the laser system to classification 3R, which is the same as the predicate devices.

The battery conforms to IEC 62133.

Summary

Based on the above performance as documented in this application, Laser Therapy Hair Growth Comb was found to have a safety and effectiveness profile that is same as the predicate device.

VIII. Conclusions

In accordance with the Federal Food, Drug and Cosmetic Act, 21 CFR Part 807 and based on the comparison of intended use, design, materials and performance, Laser Therapy Hair Growth Comb is to be concluded same to its predicate devices.